November 30, 2016 - By Marguerite Chambers · 0 Comments
The stock of Concordia International Corporation (NASDAQ:CXRX) registered an increase of 4.11% in short interest. CXRX’s total short interest was 11.41M shares in November as published by FINRA. Its up 4.11% from 10.96M shares, reported previously. With 3.35M shares average volume, it will take short sellers 3 days to cover their CXRX’s short positions. The short interest to Concordia International Corporation’s float is 28.14%. About 536,558 shares traded hands. Concordia International Corp (NASDAQ:CXRX) has declined 91.70% since April 27, 2016 and is downtrending. It has underperformed by 96.93% the S&P500.
Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $134.17 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.
Out of 9 analysts covering Concordia Healthcare Corp. (NASDAQ:CXRX), 5 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 56% are positive. Concordia Healthcare Corp. has been the topic of 18 analyst reports since August 11, 2015 according to StockzIntelligence Inc. The stock of Concordia International Corp (NASDAQ:CXRX) earned “Sector Perform” rating by IBC on Monday, November 30. On Tuesday, March 29 the stock rating was maintained by Laurentian with “Buy”. The firm has “Hold” rating by GMP Securities given on Monday, August 15. The firm has “Outperform” rating given on Thursday, October 1 by RBC Capital Markets. On Friday, October 16 the stock rating was maintained by S&P Research with “Buy”. Scotia Capital maintained the stock with “Sector Outperform” rating in Tuesday, September 29 report. Scotia Capital maintained the stock with “Sector Outperform” rating in Friday, October 16 report. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, August 11. TD Securities downgraded Concordia International Corp (NASDAQ:CXRX) on Thursday, August 4 to “Hold” rating. The stock has “Neutral” rating given by Goldman Sachs on Monday, June 6.
More recent Concordia International Corp (NASDAQ:CXRX) news were published by: Prnewswire.com which released: “Concordia International Corp. Announces CEO Transition Plan” on October 21, 2016. Also Prnewswire.com published the news titled: “Concordia International Corp. Announces Communication With CMA” on October 25, 2016. Prnewswire.com‘s news article titled: “Shareholder Class Action Filed Against Concordia International Corp. – CXRX” with publication date: August 17, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Marguerite Chambers